Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients

• Lin Hu ,

  Roles Data curation, Project administration, Writing – original draft

  * E-mail: 1150721071@qq.com (LH); 326366726@qq.com (GH)

  Affiliation Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China

  https://orcid.org/0000-0001-6098-5196

  ⨯
• Shiqiong Huang,

  Roles Data curation

  Affiliation Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China

  ⨯
• Qi Huang,

  Roles Investigation

  Affiliation Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Juanjuan Huang,

  Roles Writing – review & editing

  Affiliation Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China

  ⨯
• Zeying Feng,

  Roles Software

  Affiliations Clinical Trial Institution Office, Liuzhou Hospital of Guangzhou Women and Children’s Medical Center, Liuzhou, Guangxi, China, Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Gefei He

  Roles Writing – review & editing

  * E-mail: 1150721071@qq.com (LH); 326366726@qq.com (GH)

  Affiliation Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China

  ⨯